Shareholders approve preferential issue and share split at AGM
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.7 pts less than Nifty Microcap 250 and 4.1 pts less than its Pharmaceuticals & Biotechnology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
At 34th AGM on Sep 29 2026, shareholders approved a preferential issue of up to 19,60,92,244 equity shares at INR 10 each, totalling INR 196.09 crore. This includes INR 18 crore cash to 3 non-promoters plus shares for acquiring 45 percent of CCME UAE from 2 promoters and 52 percent of Interlink Distribution LLC. Also approved a 1:10 share split (INR 10 to INR 1 face value), authorised capital hike from INR 60 crore to INR 200 crore, and shift of registered office from Andhra Pradesh to Mumbai.
Major dilution from preferential issue and acquisitions. Share split aims to improve liquidity and attract small investors. Results awaited.